EQH Options Shift as Bulls Await the Real Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Equitable Holdings reported July 30 results — but the earnings event that matters most arrives Monday, August 4, and the most striking development heading into it is a sharp reversal in options sentiment.
Options positioning has turned dramatically more bullish in the past week. The put/call ratio dropped to 0.92, nearly 2.3 standard deviations below its 20-day mean of 1.60 — a swing that marks call buying running well ahead of protective put demand. That is a sharp pivot from the defensive tilt that characterised positioning through most of June and July, when the PCR ran as high as 2.08. The stock itself closed at $47.65, down about 2.5% on July 31, though it has gained more than 8% over the past month — so the one-day dip looks less like a reversal and more like consolidation after a strong run.
The analyst consensus remains firmly constructive. Targets were raised across the board in early July: UBS sits at $68, Jefferies at $66, Evercore ISI at $65, with Keefe Bruyette and Mizuho both at $62. The mean target of $60.82 implies roughly 28% upside from current levels — a gap that has barely narrowed despite July's rally. Bears can point to the fact that the stock has still not closed that discount, even after a strong earnings beat in May that pushed shares up more than 5% in a single session. Barclays remains the lone note of caution with a $50 target, still Overweight but flagging valuation. Bulls counter with a trailing PE near 6x and an EPS surprise rank in the 83rd percentile, suggesting the company has a strong habit of clearing the bar.
Insider activity leans more cautious. CEO Mark Pearson sold nearly $1.9 million worth of shares on July 20 at around $48.54, following a similar $1.8 million sale in June. COO Jeffrey Hurd also sold across multiple tranches in July, totalling around $700,000. Neither sale is enormous relative to the company's size, and both carry low trade-significance scores — but the pattern of selling near current prices, rather than waiting for the Street's $60-plus targets, is a quiet counterweight to the bullish analyst narrative. On the short side, bears have largely stepped back: SI has fallen more than 44% in a month to just 1.8% of the free float, with borrow availability extremely loose and cost to borrow below 0.35%. There is no squeeze dynamic at play here.
Monday's print will test whether EQH's improving earnings trajectory — and the conviction behind six consecutive analyst target raises — can finally push the stock meaningfully toward the Street's valuation, or whether the insider selling near $48 is pricing in a ceiling the market already understands.
Stocks in this article
See the live data behind this article on ORTEX.
Open EQH on ORTEX →How this article was generated
- Generated
- 1 Aug 2026, 04:25
- Data as of
- 1 Aug 2026, 04:06
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
- Validation notes
- soft: missing section mentions: short interest (informational only)
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.